Author(s)

Abdourahamane Diallo^1,2*, Mamadou Hady Diallo^2,3, Fatoumata Bamba Diallo^2,3, Ibrahima Koussy Bah^1,2, Boubacar Siddy Diallo¹, Ibrahima Sory Balde^1,2, Telly Sy^1,2, Namory Keita^2,3

¹Gynecology-Obstetrics Department, Ignace Deen National Hospital, Conakry, Guinea.
²Faculty of Health Sciences and Techniques, Gamal Abdel Nasser University of Conakry, Conakry, Guinea.
³Gynecology-Obstetrics Department, Donka National Hospital, Conakry, Guinea.

Background: Ovarian cancer is the seventh most common cancer in women in the world and is the leading cause of death among gynecological cancers. Objective: The objective of this study was to describe the clinical, therapeutic and prognostic aspects of ovarian cancer in the both Gynecology-Obstetrics departments Donka and Ignace Deen of the Conakry University Hospital. Methods: This was a retrospective, descriptive study lasting 12 years from January 1, 2011 to December 31, 2022, covering the files of patients treated for ovarian cancer in the both Gynecology-Obstetrics departments Donka and Ignace Deen. The study focused on the epidemiological, clinical, histological and therapeutic aspects of the disease. Results: In total, 135 files of patients with ovarian cancer were collected out of the 3821 files of gynecological pathologies recorded in the two departments during the study period, either a frequency of 3.5%. Among gynecological and breast cancers, ovarian cancer represented 9.1%. The average age of the patients was 46.3± 17.8 years and the average parity was 4 ± 3. The revealing clinical signs were dominated by pelvic pain (92.6%) and increased abdominal volume (53.3%). The diagnosis of the disease was made mainly at stages III and IV (71.9%). The most common histological type was serous papillary adenocarcinoma (57.0%). Exclusive surgical treatment was performed in 8.1% of patients, surgery combined with chemotherapy in 63.0% of patients and exclusive chemotherapy in 11.1% of patients. After an average follow-up of 42 months, 29 patients out of the 96 operated on were alive (30.2%), 51 had died (53.1%) and 16 patients were lost to follow-up (16.7%). Conclusion: Ovarian cancer is the third most common cancer in both departments. Diagnosis is often late and the prognosis is poor.

Cancer, Ovary, Ignace Deen, Donka

Diallo, A. , Diallo, M. , Diallo, F. , Bah, I. , Diallo, B. , Balde, I. , Sy, T. and Keita, N. (2023) Ovarian Cancer: Clinical, Therapeutic and Prognostic Aspects at the University Hospital Center of Conakry in Guinea. Open Journal of Obstetrics and Gynecology, 13, 1985-1993. doi: 10.4236/ojog.2023.1312168.